Navigation Links
Susan G. Komen for the Cure, Karmanos Cancer Institute, Community Leaders, Breast Cancer Survivors and Activists to Gather at Forum and Call for Action on Breast Cancer
Date:10/23/2007

Komen Detroit Race for the Cure to Join Nationwide Campaign Challenging

U.S. to Close the Gaps in Breast Cancer Care, Survival

DETROIT, Oct. 23 /PRNewswire/ -- On October 23 and 25, Komen Detroit Race for the Cure will host events to launch Metro Detroit's participation in the Komen Community Challenge. The Detroit Community Challenge events mark the twelfth stop of the 25-city campaign to elevate breast cancer on the national agenda and to draw attention to disparities in breast cancer mortality.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

On October 23, physicians and executives from five of metro Detroit's top hospitals, breast cancer survivors and elected officials will come together for a Community Forum at the Max M. Fisher Center to discuss strategies for addressing high mortality rates in Wayne County and disparities that prevent low-income women from receiving quality care. Earlier that day, the Komen On the Go(TM) community education vehicle will be at University of Michigan - Dearborn, where volunteers will answer questions and offer information about breast health. On October 25, Komen On the Go(TM) will be at Wayne State University.

Nationwide, one in eight women will get breast cancer in her lifetime. Many Americans -- racial and ethnic minorities, low income women and those with little or no health insurance -- are less likely to receive quality cancer care and are more likely to die from the disease.

Tuesday, October 23, 6:00pm - 8:00pm

WHAT: 'Close the Gap' Community Forum. Reception with silent auction

followed by discussion and interactive community forum.

WHO: Rene Syler, author, TV personality and breast cancer advocate

Kimberly Simpson, Chief Operating Officer, Susan G. Komen for the

Cure

Dr. John C. Ruckdeschel, P
'/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Vitamin B12 can help in detecting cancers
6. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
7. Consensus on "Combination Therapy" for Breast Cancer
8. Cancers of Colon & Rectum linked to Cigarette Smoking
9. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
10. The Cancer Rumour mill working over time
11. Want skin cancer? Please have a cigarette
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2013)... Dearborn Foot and Ankle Doctor , Dr. Lawrence ... on his new website for his three decade old ... available on Dr. Young’s website, Podiatry.md, has common symptoms and ... it affects the foot specifically. , Dr. Young had this ... an inevitability for many. We’ve treated arthritis-ridden feet for many ...
(Date:12/21/2013)... PA (PRWEB) December 21, 2013 ... diseases from one patient to the next, an ... SKIN GUARD. , The accessory safeguards the patient's ... which keeps the patient from developing infections and ... the invention is easy to use and features ...
(Date:12/21/2013)... to sweat. Angie puts a new spin on old moves. ... same time which will have the legs SCREAMING by the ... tricep and inner thigh exercises, utilizing isometric movements along with ... The DVD has 10 various premixes consisting of 5 short ... a challenge for the most advanced exerciser. Although the exercises ...
(Date:12/21/2013)... Los Angeles (PRWEB) December 21, 2013 The ... to find out who its female members think is the ... in November to find out. The poll asked the female ... were. They were given the choice of ten attractive actors ... a month, then tallied the results. , After checking ...
(Date:12/21/2013)... After surpassing its original fundraising goal of raising ... extended fundraising goal of $30,000 according to Kicking For ... says he is overwhelmed by the success of Kicking ... still raising money – and awareness- with 9 days ... that we have reached our goal of raising $30,000,” ...
Breaking Medicine News(10 mins):Health News:Sterling Heights Foot and Ankle Doctor Releases Foot and Ankle Arthritis Article on Podiatry.MD 2Health News:Angie Gorr Puts the Fun Back Into Home Workout DVDs; Ultimate Sweat and Tone Was Just Released Oct 2013; Angie Gives a Whole New Meaning to Kicking Butt 2Health News:PositiveSingles Results of “Hottest Actor” Poll Are In 2Health News:Kicking For The Dream Reaches $30,000 Fundraising Goal to Fight Ovarian Cancer with 9 Days Left in its Fundraising Campaign. 2Health News:Kicking For The Dream Reaches $30,000 Fundraising Goal to Fight Ovarian Cancer with 9 Days Left in its Fundraising Campaign. 3
... is the most shocking ... Luther King, Jr., WASHINGTON, Sept. 27 "Everybody knows that ... nation that it,is also unfair," said Gary A. Puckrein, PhD, at ... White majority in this,country as the norm while it neglects the ...
... Spain: One of the largest individual studies of the effects ... that it makes no difference whether a woman drinks wine, ... (ethyl alcohol) and the quantity consumed that is likely to ... from drinking three or more alcoholic drinks a day is ...
... New research offers reassurance to women worried about whether ... , The study by Norwegian scientists, presented today ... Barcelona, found that for almost all types of cancer, ... or who became pregnant after being treated for the ...
... A new study adds fuel to the debate over whether ... cancer. , The study, presented by Australian ... in Barcelona, found some evidence suggesting exercise might increase the ... study included 24,479 Australian women aged between 27 and 75, ...
... Pink To Promote Breast Cancer Awareness, LOS ANGELES, ... partnership with Susan G. Komen for the Cure to ... spreader that features the pink breast,cancer awareness ribbon. The ... Breast Cancer Awareness Month and the program will,continue for ...
... SCHAUMBURG, Ill., Sept. 27 Sagent Pharmaceuticals,Inc., ... the,closing of a $53 million Series A ... financing will be used primarily to fund ... business,initiatives, including numerous development, sales and marketing,manufacturing ...
Cached Medicine News:Health News:Civil Rights and Medical Leaders Call for Social Justice in Health Care 2Health News:Civil Rights and Medical Leaders Call for Social Justice in Health Care 3Health News:Civil Rights and Medical Leaders Call for Social Justice in Health Care 4Health News:Civil Rights and Medical Leaders Call for Social Justice in Health Care 5Health News:Wine, women and... spirits, beer and breast cancer risk 2Health News:Wine, women and... spirits, beer and breast cancer risk 3Health News:Study indicates pregnancy does not harm chances of survival from cancer 2Health News:Study fuels debate over whether exercise and body size influence ovarian cancer risk 2Health News:Study fuels debate over whether exercise and body size influence ovarian cancer risk 3Health News:Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer 2Health News:Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing 2
(Date:12/20/2013)... Today, Analysts, Corner announced new research ... Fisher Scientific, Inc. (NYSE: TMO ), DaVita, Inc. ... UTHR ), and Keryx Biopharmaceuticals Inc. (NASDAQ: KERX). Today,s ... full price targets, industry analysis and analyst ratings - via ... On December 17, 2013, Perrigo Co.,s (Perrigo) stock increased ...
(Date:12/20/2013)... JERUSALEM , Dec. 20, 2013 ... a clinical-stage pharmaceutical company focused on the development ... results in a clinical trial testing the pharmacokinetic ... in type 1 diabetes patients.  ... oral insulin at each study visit; blood glucose ...
(Date:12/19/2013)... Dec. 19, 2013  Intra-Cellular Therapies, Inc. ("ITI"), ... therapeutics for CNS disorders, announced that its common ... OTC Markets – OTCQB tier (OTCQB) under the ... on December 20, 2013. ABOUT INTRA-CELLULAR ... developing novel drugs for the treatment of neuropsychiatric ...
Breaking Medicine Technology:Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals 2Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals 3Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals 4Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals 5Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes 2Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes 3Oramed Announces Successful Results from Ex-US Pharmacokinetic Study of its Oral Insulin for the Treatment of Type 1 Diabetes 4Intra-Cellular Therapies Cleared for Quotation on OTCQB 2Intra-Cellular Therapies Cleared for Quotation on OTCQB 3
... - Gilead,Sciences, Inc. (Nasdaq:GILD) today announced that ... the company's once-daily,anti-HIV drug Viread (tenofovir disoproxil ... potential treatment for chronic hepatitis B virus,(HBV) ... study shows,that Viread is non-inferior to the ...
... at the Movement Disorder Society's 11th,International Congress in ... /PRNewswire-FirstCall/ -- New,information on the use of AZILECT(R) ... was reported this week at The,Movement Disorder Society's ... the FDA May 17, 2006, for the,treatment of ...
Cached Medicine Technology:Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 2International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 3International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 5International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 6
Viscoelastic Cannula, 23 g. Angled. 7 mm angled tip cannula with unique hub that facilitates flow of viscoelastic material. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 21 g., 8 mm from bend to tip. Overall length 25 mm. 5/box....
Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
Anterior Chamber Needle, 20 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Medicine Products: